New Strategies for Managing Single-Use Components
Dual-sourcing and redundant manufacturing capabilities are crucial in a single-use supply chain strategy, but must be applied correctly.
As single-use systems (SUS) have increasingly been implemented in GMP biopharmaceutical production, supply-chain assurance for SUS materials, components, and assemblies has become even more important. Dual-sourcing and redundant manufacturing capabilities are crucial in a single-use supply chain strategy. However, these tenets of supply-chain management are often misapplied and undervalued, leading to potential risk that can result in delays or even stoppages in critical drug production.
Read this article in BioPharm International's Single-Use Systems 2019 eBook.
Article Details
BioPharm International
eBook: Single-Use Systems
Vol. 32
June 2019
Pages: 10–13
Citation
When referring to this article, please cite it as T. Korwan and J. Harp, " New Strategies for Managing Single-Use Components," BioPharm International Single-Use Systems eBook (June 2019).
Thermo Fisher Opens Advanced Therapies Collaboration Center in California
April 18th 2025The 6000-square-foot facility will provide cell therapy developers the support they need to transition to CGMP manufacturing, and an expanded footprint of the new center is expected to open in Philadelphia later in 2025.
